drugset / Trial / NCT01139151
4'-Thio-araC (Thiarabine) in Advanced Hematologic Malignancies
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The goal of this clinical research study is to find the highest tolerable dose of 4'-thio-araC (thiarabine) that can be given to patients with advanced blood cancer. The safety of this drug will also be studied and 2 different dose schedules will be tested.
Timeline
- Start
- 2010-08
- Primary completion
- 2011-11
- Completion
- 2013-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Thiarabine | Small molecule | 40 mg/m2 | Intravenous |
| Subject | Thiarabine | Small molecule | 70 mg/m2 | Intravenous |